相似文献
1
Treating depression and substance use: a randomized controlled trial.
J Subst Abuse Treat. 2012 Sep;43(2):137-51. doi: 10.1016/j.jsat.2011.12.004. Epub 2012 Feb 1.
2
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
J Consult Clin Psychol. 2012 Jun;80(3):404-15. doi: 10.1037/a0028208. Epub 2012 Apr 30.
3
Training addiction counselors to implement CBT for depression.
Adm Policy Ment Health. 2011 Jul;38(4):313-23. doi: 10.1007/s10488-011-0359-7.
4
Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
Am J Psychiatry. 2021 May 1;178(5):414-423. doi: 10.1176/appi.ajp.2020.20040454. Epub 2020 Oct 29.
5
An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment.
Arch Gen Psychiatry. 2011 Jun;68(6):577-84. doi: 10.1001/archgenpsychiatry.2011.53.
6
Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial.
JAMA Netw Open. 2019 Jan 4;2(1):e186927. doi: 10.1001/jamanetworkopen.2018.6927.
7
Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy.
J Subst Abuse Treat. 2009 Dec;37(4):412-20. doi: 10.1016/j.jsat.2009.04.006. Epub 2009 Jun 21.
8
Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!).
J Clin Psychiatry. 2008 Jan;69(1):122-9. doi: 10.4088/jcp.v69n0116.
9
Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial (DeCoDer study).
Health Technol Assess. 2017 Jun;21(35):1-164. doi: 10.3310/hta21350.
10
The impact of depression on the outcome of addictions treatment.
J Subst Abuse Treat. 1998 Mar-Apr;15(2):123-30. doi: 10.1016/s0740-5472(97)00183-9.
引用本文的文献
1
Feasibility in Community Mental Health Research: A Scoping Review.
Adm Policy Ment Health. 2025 Jun 29. doi: 10.1007/s10488-025-01457-8.
2
Resilience and relapse risk in Emirate adult patients with substance use disorder: a national cross-sectional study from the United Arab Emirates.
Front Psychiatry. 2024 Sep 24;15:1444233. doi: 10.3389/fpsyt.2024.1444233. eCollection 2024.
3
The influence of therapy quality on outcomes from behavioural activation and guided self-help treatments for depression in adults with intellectual disabilities.
Br J Clin Psychol. 2025 Jun;64(2):139-147. doi: 10.1111/bjc.12502. Epub 2024 Sep 3.
4
Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index.
Res Sq. 2023 Nov 30:rs.3.rs-3682009. doi: 10.21203/rs.3.rs-3682009/v1.
5
Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.
Drug Alcohol Depend. 2019 Jan 1;194:230-237. doi: 10.1016/j.drugalcdep.2018.09.010. Epub 2018 Oct 29.
6
Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study.
BMC Psychiatry. 2018 Jun 13;18(1):189. doi: 10.1186/s12888-018-1770-3.
7
Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada.
Subst Abuse Treat Prev Policy. 2018 Jan 19;13(1):3. doi: 10.1186/s13011-018-0142-9.
8
Bayesian models for semicontinuous outcomes in rolling admission therapy groups.
Psychol Methods. 2017 Dec;22(4):725-742. doi: 10.1037/met0000135.
9
RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk.
PLoS One. 2017 Dec 14;12(12):e0187180. doi: 10.1371/journal.pone.0187180. eCollection 2017.
10
Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?
J Subst Abuse Treat. 2014 Jul;47(1):78-85. doi: 10.1016/j.jsat.2014.02.005. Epub 2014 Mar 1.
本文引用的文献
1
Support for Students Exposed to Trauma: A Pilot Study.
School Ment Health. 2009 Jun 1;1(2):49-60. doi: 10.1007/s12310-009-9007-8.
2
Can paraprofessionals deliver cognitive-behavioral therapy to treat anxiety and depressive symptoms?
Bull Menninger Clin. 2010 Winter;74(1):45-62. doi: 10.1521/bumc.2010.74.1.45.
3
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
Am J Psychiatry. 2010 Jun;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852. Epub 2010 Mar 15.
4
Dynamic association between negative affect and alcohol lapses following alcohol treatment.
J Consult Clin Psychol. 2009 Aug;77(4):633-44. doi: 10.1037/a0015647.
5
Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy.
J Subst Abuse Treat. 2009 Dec;37(4):412-20. doi: 10.1016/j.jsat.2009.04.006. Epub 2009 Jun 21.
6
Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later.
Clin Psychol Rev. 2009 Jul;29(5):449-58. doi: 10.1016/j.cpr.2009.04.005. Epub 2009 Apr 18.
7
A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.
J Subst Abuse Treat. 2009 Oct;37(3):318-25. doi: 10.1016/j.jsat.2009.03.005. Epub 2009 Apr 8.
8
Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature.
BMC Psychiatry. 2009 Feb 20;9:6. doi: 10.1186/1471-244X-9-6.
9
Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599.
10
Disparities in use of mental health and substance abuse services by persons with co-occurring disorders.
Psychiatr Serv. 2009 Feb;60(2):217-23. doi: 10.1176/ps.2009.60.2.217.
Zotero 插件